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Civil society, including addiction practitioners, 
have been actors in policy spaces since United 
Nations (UN) drug control debates began un-
der the Leagues of Nations (Bruun, 1975). Since 
the early 1990s, prime responsibility for UN 
drug-related matters has been held by Vienna-
based institutions. Although initially experi-
encing limited space for engagement with UN 
institutions and Member States, opportunities 
for civil society to influence international drug 
policy have grown, with the recognition of the 
importance of collaboration with non-govern-
ment organisations (NGOs) increasing across 
all major UN agencies and institutions manag-
ing drug-related matters. This paper aims to 
provide knowledge on international drug poli-
cy and the role and engagement of civil society, 
highlight interagency approaches and various 
opportunities for civil society engagement, 
and call to attention possibilities for addiction 
practitioners to influence international drug 
policy. 
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Summary
This paper discusses civil society engagement in drug policy making processes and political spaces at the 
United Nations. Reviewing the structure of international drug policy making, mechanisms of NGO participa-
tion, its challenges, and the considerable progress in changing the landscape of the debates at the Commission 
on Narcotic Drugs, the authors offer their practical expertise. The make-up and functioning of the global drug 
control system, the interagency approaches at play, and the role of civil society in the international structure of 
drug policy making is explained. The paper takes account of the history of civil society engagement, the efforts 
of non-state actors to influence high-level debates and offers practical ways for practitioners and non-diplomats 
to be involved in advocating for and engaging in policy reform from the ground.
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Zusammenfassung
Dieses Papier diskutiert das zivilgesellschaftliche Engagement bei drogenpolitischen Entscheidungspro-
zessen bei den Vereinten Nationen. Die Autoren geben einen Überblick über die Struktur der internationalen 
Drogenpolitik, die Mechanismen der Beteiligung von Nichtregierungsorganisationen, ihre Herausforderungen 
und die beträchtlichen Fortschritte bei der Veränderung der Debatten in der Suchtstoffkommission und bieten 
ihre praktische Expertise an. Der Aufbau und die Funktionsweise des globalen Drogenkontrollsystems, die be-
hördenübergreifenden Ansätze und die Rolle der Zivilgesellschaft in der internationalen Struktur der Drogen-
politik werden erläutert. Der Beitrag berücksichtigt weiters die historische Entwicklung des zivilgesellschaft-
lichen Engagements, die Bemühungen nichtstaatlicher Akteure, die Debatten auf hoher Ebene zu beeinflussen, 
und bietet praktische Möglichkeiten für Praktiker und Nicht-Diplomaten, sich für politische Reformen vor Ort 
einzusetzen und zu engagieren. 
Schlüsselwörter: Beteiligung der Zivilgesellschaft, Vereinte Nationen, internationales Drogenkontrollsystem, 
Reform der Drogenpolitik
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History of drug-related international 
conventions and UN structures
Early drug-related conventions and the 
UN system (1909–1945)
International forums to discuss drug-related 
matters can be traced as far back as 1909 – to 
the Shanghai Opium Commission, originally or-
ganised to exchange data and information on 
opium trade and consumption, enable identifi-
cation of main opium trade flows, and to bring 
together all the major producing, manufactur-
ing and drug consuming nations (United Na-
tions, n.d.). The 1909 Commission paved the 
way for the first international drug convention 
in 1912, the International Opium Convention of 
The Hague, which formally established narcot-
ics control as an element of international law. 
The 1912 Convention established the ground-
work of the current international drug control 
system and included concern for public health – 
restricting those member states to use drugs 
for medical and other legitimate purposes only 
(Fedetov, 2012). Over the next few decades other 
conventions, protocols and agreements relat-
ing to international drug-related matters were 
agreed upon – including: the 1925 amendment 
to the International Opium Convention (to extend 
restrictions to control cannabis along with opi-
um), the 1931 Convention for Limiting the Manu-
facture and Regulating the Distribution of Narcotic 
Drugs, and the 1936 Convention for the Suppres-
sion of the Illicit Traffic in Dangerous Drugs. 
The Commission on Narcotic Drugs  
(1946–current)
The Commission on Narcotic Drugs (CND) is 
the principle policy-making body of the United 
Nations (UN) with responsibility for drug-re-
lated matters. CND was first established in 1946 
in New York as a functional commission of the 
UN Economic and Social Council (ECOSOC) – 
designed to carry out specific responsibilities 
within the mandates assigned to ECOSOC. 
CND supervises the application of internation-
al drug control treaties and advises on all as-
pects of the control of psychotropic substances 
and their precursors globally. 
The CND meets annually to consider and 
adopt a range of decisions and resolutions re-
lated to drugs policies. The 53 elected member 
states that formally comprise the CND (United 
Nations Office of Drugs and Crime)1 also decide 
on the (re)classification of narcotic drugs and 
psychotropic substances under international 
control, based on the recommendations from 
the World Health Organization (United Nations 
Office of Drugs and Crime, 2020). Ever since the 
very first meeting of the CND in 1947, some civil 
society organisations (CSOs)/non-governmen-
tal organisations (NGOs) were documented as 
being in attendance (Fordham, 2018).
Throughout the history of the CND, addi-
tional protocols regarding international drug-
related matters were signed by member states – 
including the 1948 Synthetic Narcotics Protocol 
(United Nations Office of Drugs and Crime). Be-
tween 1954 and 1964, civil society involvement 
at CND sessions continued to be documented 
(Fordham, 2018). 
The International Drug Control  
Conventions (1961, 1971 and 1988)
The modern-day international drug control sys-
tem is based on three UN treaties: 
1)  the Single Convention on Narcotic Drugs (1961, 
amended by the 1972 Protocol),
2)  the Convention on Psychotropic Substances 
(1971),
3)  and the Convention Against Illicit Traffic in 
Narcotic Drugs and Psychotropic Substances 
(1988). 
The main purpose of all three conventions is to 
prevent the “misuse” of psychoactive substanc-
1 It is worth noting that all other Un member states are able to 
participate fully in cnD meetings, with the sole exception of 
when votes are held.
The Vienna nGO committee on Drugs (VnGOc) is a non-governmental organisation, legally registered in Austria. It 
was founded in 1983 to provide a link between nGOs around the world and the Un’s drug control bodies and fora 
based in Vienna. Its main organizational objective is to support nGOs to engage with the Un on matters related to 
drug policy, strategy and practice (Vienna nGO committee on Drugs). The VnGOc currently has around 250 mem-
bers from every region of the world (Vienna nGO committee on Drugs), spanning a broad range of perspectives and 
expertise, providing a wide range of interventions to prevent illicit/harmful drug use and related problems, and the 
committee is steered by a democratically elected board. 
established just one year later, in 1984, the new York nGO committee on Drugs (nYnGOc) also provides a platform 
for the discussion of drugs and drug-related subjects between nGO members from around the world and the Un, 
especially the General Assembly and ecOSOc based in new York (new York nGO committee on Drugs). The nYnGOc 
currently has around 100 members from all regions.
The two committees have a long history of collaborations, as will be explored later in this paper. Many nGOs are 
also members of both committees simultaneously, in order to stay connected with the Un drug discourse across 
different hub cities.
Box 1
The nGO committees  
on Drugs (Vienna and  
new York)
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es, while simultaneously ensuring their avail-
ability for medical and scientific purposes. The 
1961 and 1971 Conventions classify substances 
based on their alleged harmfulness and thera-
peutic value into four schedules, broadly indi-
cating the level of control they each require. The 
1961 Convention also established the Interna-
tional Narcotics Control Board (INCB) – an inde-
pendent, quasi-judicial expert body established 
to act as a “watchdog” of the treaties. The 1988 
Convention binds countries to target all aspects 
of illicit drug production, trafficking, and pos-
session with criminal sanctions, and establishes 
the control of chemicals, reagents, and solvents 
used in illicit drug production. In order to en-
sure the functioning of the drug control system, 
these treaties assign official roles to three insti-
tutions within the UN system: 
1) the CND,
2) the INCB,
3) and the World Health Organization (WHO).
High-level UN meetings and  
developments on drug-related matters 
since the 1980s
A high-level ministerial segment, the Interna-
tional Conference on Drug Abuse and Illicit Traf-
ficking was convened in Vienna in 1987 (United 
Nations Office of Drugs and Crime, 1987), to 
generate universal action on drug-related mat-
ters – just prior to the formal adoption of the 1988 
Convention. It was accompanied by the first civ-
il society international forum, co-organised by 
the VNGOC and NYNGOC; to build on these 
discussions, the General Assembly devoted its 
first Special Session (UNGASS) to the drugs is-
sue in February 1990 (United Nations General 
Assembly, 1990), adopting a Political Declaration 
and Global Programme of Action, which men-
tioned the relevance of NGOs in contribution 
to drug education programmes (Paragraph 11) 
and demand reduction (Paragraph 33). 
With the recognition of the need for a more 
integrated and comprehensive approach to 
drug-related matters, the ECOSOC and the UN 
Secretary-General created the UN International 
Drug Control Programme (UNDCP) in 1991 to co-
ordinate effective leadership in UN drug con-
trol matters and ensure adequate financial and 
other resources were allocated to drug-related 
matters (United Nations Office of Drugs and 
Crime, 1991).
The UNDCP supported the NGO World 
Forum on Drug Demand Reduction led by the 
VNGOC and NYNGOC in Bangkok, Thailand 
in 1994, where the NGO Bangkok Declaration 
(NGO Committee on Narcotics and Substance 
Abuse, 1994) was established by representatives 
of NGOs from 112 countries, noting concern for 
rising trends in drug demand, the need for com-
prehensive and culturally specific approaches, 
and that the stigmatisation of people who use 
drugs violates human rights principles.
The UN Office for Drug Control and Crime 
Prevention was then established in 1997 by com-
bining the UNDCP and the Crime Prevention 
and Criminal Justice Division – and was later 
renamed the United Nations Office on Drugs and 
Crime (UNODC) in 2002. 
A second UNGASS relating to drugs was 
held in New York in 1998, aiming to counter the 
world drug problem by controlling precursors, 
achieving significant results in demand reduc-
tion, and eliminating or significantly reducing 
cultivation of coca, cannabis and opium by 2008 
(United Nations General Assembly, 1998b). The 
1998 UNGASS had one official side event led by 
civil society, and an “NGO village” space was 
jointly coordinated by the VNGOC and NYN-
GOC just outside of the UN building to support 
the engagement of the handful of NGOs present 
(Fordham, 2018). The Special Session resulted 
in a new Political Declaration (United Nations 
General Assembly, 1998b) – which called upon 
“non-governmental organizations and the me-
dia worldwide actively to promote a society 
free of drug abuse” (Paragraph 12) – and an ac-
companying “Declaration on the Guiding Prin-
ciples on Demand Reduction” (United Nations 
General Assembly, 1998a). 
As the ten-year anniversary and review of 
the 1998 UNGASS approached, a ‘Beyond 2008’ 
NGO Forum and global consultation was host-
ed by the UNODC, VNGOC and NYNGOC – 
the first ever initiative for civil society engage-
ment at this scale (“Beyond 2008” Forum, 2008). 
More than 200 NGOs, including addiction pro-
fessionals, attended the Forum itself, agreeing 
by consensus a declaration and three resolu-
tions which were then formally submitted to 
member states to inform their deliberations – 
with mixed impact. “Beyond 2008” had three 
main objectives: to highlight NGO achieve-
ments in the field of drug control, to review and 
propose best practices related to collaboration 
mechanisms among NGOs, governments and 
UN agencies, and to adopt a series of high-or-
der principles to table with UNODC and CND 
(United Nations Office of Drugs and Crime, 
2008).
CND also passed a resolution (Resolution 
51/4) in 2008, that specifically encouraged civil 
society to partake in the preparatory process 
for the following high-level segment planned 
for 2009 (The Commission on Narcotic Drugs, 
2009). 2008 was also the first year that “informal 
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dialogues“ were held between civil society and 
senior UNODC officials, aiming to aid commu-
nication between civil society and UN bodies 
(Fordham, 2018). Today, these dialogues are still 
held every year with the Executive Director of 
the UNODC, the President of the INCB, and the 
CND Chair. 
A high-level segment of CND was held in 
Vienna in 2009 (rather than another UNGASS 
in New York), where the Political Declaration and 
Plan of Action on International Cooperation towards 
an Integrated and Balanced Strategy to Counter the 
World Drug Problem was adopted. Perhaps influ-
enced by the “Beyond 2008” efforts, the Political 
Declaration highlighted the important role of 
civil society, and noted that representatives of 
affected populations and civil society entities 
should be enabled to play participatory roles 
in the formulation and implementation of drug 
policies, where appropriate (United Nations Of-
fice of Drugs and Crime, 2009).
In 2011, the CND adopted its first resolution 
focused on civil society: CND Resolution 54/11 
entitled Improving the participatory role of civil 
society in addressing the world drug problem (The 
Commission on Narcotic Drugs, 2011), followed 
up by an invitation to Member States to report 
on their experiences working with civil society 
(Commission on Narcotic Drugs, 2012).
In 2012, the Presidents of Mexico, Colom-
bia and Guatemala formally requested the UN 
General Assembly to hold another Special Ses-
sion on drugs and urged the UN and member 
states to “conduct an in-depth review […] in or-
der to establish a new paradigm”. The UNGASS 
was eventually confirmed for April 2016 and 
prompted the reinvigoration of the NYNGOC 
(which had become dormant in the preceding 
years). In December 2014 (several months after 
the mid-term UNODC high-level review on 
the implementation of the 2009 Political Dec-
laration), the VNGOC and NYNGOC formally 
launched a Civil Society Task Force (CSTF; see 
Box 2) to act as the official civil society plat-
form for the UNGASS (United Nations Office of 
Drugs and Crime).
The following year, 2015, brought the first 
opportunity for the CSTF to work together on 
the selection of geographically diverse civil 
society speakers to the UN General Assembly 
Thematic Debate on drugs in New York (Ford-
ham, 2018). Also that year, the broader 2030 Sus-
tainable Development Agenda was adopted in 
New York by member states and the whole UN 
system, incorporating a range of goals and tar-
gets relevant to international drug policy, and 
embodying collaboration with global civil soci-
ety throughout (United Nations).
The CSTF worked with the President of the 
General Assembly’s Office in 2016 to hold Infor-
mal Interactive Stakeholder Consultations in New 
York in the months leading up to the UNGASS, 
with the inclusion of over 300 civil society rep-
resentatives submitting more than 50 interven-
tions. However, many preparatory meetings for 
the UNGASS were closed to civil society, with 
certain organisational shortcomings limiting 
planned civil society participation (Fordham, 
2018).
The 2016 UNGASS itself brought new op-
portunities for civil society involvement. Hun-
dreds of NGOs attended the event in New 
York, including many addiction professionals, 
and the CSTF selected 11 civil society speakers 
for the roundtable sessions despite extensive 
screening and scrutiny from UN officials. The 
President of the General Assembly (PGA) spe-
cifically mentioned the role and visibility of civ-
il society in his closing remarks. The UNGASS 
Outcome Document (agreed by consensus by the 
CND in Vienna in the month prior to the Spe-
cial Session) contained the most comprehensive 
Mission 
To serve as the official liaison between the United nations and civil society in the preparatory process of and at the 
United nations General Assembly Special Session (UnGASS) on the world drug problem in 2016. 
Objective
To ensure a comprehensive, structured, meaningful, and balanced participation of civil society during this process.
Structure
26 members, including 18 regional representatives (two for each of: Australia, new Zealand and the Pacific; eastern 
europe and central Asia; Latin America and the caribbean; northern Africa, the Middle east and central Asia; north 
America; South Asia; South-east and east Asia; Sub-Saharan Africa; and Western europe), and eight representatives 
of affected populations and key global issues. A steering committee comprised representatives from VnGOc (as 
chair and Second Vice-chair) and nYnGOc (as First Vice-chair and Secretary).
Activities
Working closely with the UnODc civil Society Unit Team, the cSTF was established to: 
ii(i) identify speakers and participants for all relevant UnGASS 2016 preparatory events,
i(ii) lead regional consultations,
(iii) host a fourth VnGOc civil Society hearing during the 58th session of cnD, and 
(iv)  co-host with the chair of the cnD and/or the President of the General Assembly (PGA) an Interactive civil So-
ciety hearing for all stakeholders prior to the UnGASS, whose conclusions would be an officially recognized 
document of the UnGASS preparatory process (civil Society Task Force, 2015).
Box 2
The civil Society Task Force 
(cSTF)
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and supportive language to date on the impor-
tant role of civil society (Bridge, 2017), specifi-
cally with the emphasis on implementing in-
ternational drug policy with a stronger human 
rights and health-centred approach: 
“We recognise that civil society … plays an 
important role in addressing and countering 
the world drug problem, and note that affected 
populations and representatives of civil society 
entities, where appropriate, should be enabled 
to play a participatory role in the formulation, 
implementation, and the providing of relevant 
scientific evidence in support of, as appropriate, 
the evaluation of drug control policies and pro-
grammes, and we recognise the importance of co-
operation with the private sector in this regard.” 
(United Nations, 2016)
In 2018, the CSTF was reformed by VNGOC 
and NYNGOC to once again coordinate civil 
society engagement for the next UN mile-
stone in the drug control timeline – the 2019 
High-Level Ministerial Segment (marking the 
ten-year review and target date set in the 2009 
Political Declaration). The mission of the CSTF 
was broadly the same as for 2016, although the 
structure was changed slightly (for example, 
the VNGOC and NYNGOC now co-chaired 
the initiative) and the work plan was notably 
different due to there not being a large opera-
tional document to influence, nor the resources 
to conduct the same level of regional consulta-
tions as a few years prior. Crucially, this time 
the CSTF achieved a significant landmark by 
being specifically named in the CND resolution 
(Resolution 61/10) outlining the modalities for 
the High-Level Ministerial Segment (Commis-
sion on Narcotic Drugs, 2018), thereby cement-
ing the role of NGOs in the preparations.
During the 2018 launch of the UNODC 
World Drug Report, preceding the High-Level 
Ministerial Segment, the new CSTF introduced 
itself with its representatives making coordi-
nated oral statements in Vienna, New York City, 
Nairobi and Geneva. The same year, 40 civil 
society panellists and speakers took part in the 
“thematic CND intersessionals” that sought to 
follow-up on each chapter of the 2016 UNGASS 
Outcome Document. The CSTF also conducted a 
global consultation for civil society organisa-
tions, the preliminary results of which were 
presented to member states during the recon-
vened CND session in Vienna in December 
2018. 
In 2019, the CSTF hosted Civil Society Hear-
ings in New York (co-hosted by Mexico) and Vi-
enna (co-hosted by Switzerland; United Nations 
Office of Drugs and Crime, 2019b) – bringing 
together member states, UN officials and civil 
society participants to present the final consul-
tation report and highlight the role for NGOs in 
the coming decade. 
The UN High-Level Ministerial Segment it-
self then took place in March 2019 in Vienna, 
and a conference room paper was submitted by 
Switzerland on behalf of CSTF, highlighting the 
civil society views and achievements (Confer-
ence Paper 7; Commission on Narcotic Drugs, 
2019). 
Member states eventually adopted the Min-
isterial declaration on strengthening actions at the 
national, regional and international levels to acceler-
ate the implementation of joint commitments made 
to jointly address and counter the world drug prob-
lem (United Nations Office of Drugs and Crime, 
2019a). In the Declaration, member states re-
solved to review in 2029 the progress made in 
implementing the policy commitments, with a 
mid-term review in 2024. Later that year, mem-
ber states also agreed on a new four-year work 
plan to lead up to 2024 – with further thematic 
CND intersessionals dedicated to the main 
challenges and shortcomings identified in the 
2019 Ministerial Declaration. Crucially, the role 
of civil society in these meetings – as observers, 
expert panellists and speakers – has once again 
been explicitly included.
Civil society involvement in the 2019 Min-
isterial Segment was stronger than ever before. 
The CSTF Co-Chair – VNGOC Chair Jamie 
Bridge – was invited to make formal opening 
remarks at Opening Segment of Ministerial 
Segment, with civil society again selecting pan-
ellists for formal “roundtable” discussions and 
several side events. 
The relevant UN bodies and how  
they work with civil society
The United Nations Office of Drugs  
and Crime
As stated above, the UNODC was created in 
1997 and renamed in 2002 – with the goal to 
assist in better coordinating a comprehensive 
response to the inter-related issues of illicit traf-
ficking and abuse of drugs, crime prevention 
and criminal justice, international terrorism 
and political corruption. UNODC is based in 
Vienna but employs between 1,500 and 2,000 
people worldwide across country and regional 
offices as well as its headquarters. It also houses 
the Secretariats for the CND and the INCB. As 
the lead UN agency on drugs, UNODC con-
ducts research, produces normative guidance 
to support the adoption and implementation of 
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the drug control system, and provides technical 
and financial assistance to governments.
Each year, the UNODC produces the World 
Drug Report, assessing the state of internation-
al drug-related matters by providing estimates 
and information on trends in the production, 
trafficking and use of internationally scheduled 
substances; based on data and estimates collect-
ed or prepared by Governments, UNODC and 
other international institutions.
The UNODC Secretariat also houses a small 
Civil Society Unit Team to coordinate and sup-
port the agency’s various levels of engagement 
with NGOs around the world (United Nations 
Office of Drugs and Crime). The mechanisms 
for, and extent of, civil society engagement by 
UNODC varies enormously between depart-
ments and mandates – for example, the teams 
focused on HIV prevention, treatment and drug 
use prevention have an excellent track record 
of engaging civil society in their consultations 
and discussions, compared to other areas such 
as supply reduction and treaty affairs. None-
theless, in 2017, the VNGOC signed a Memoran-
dum of Understanding with the UNODC (re-
newed in 2020) to support their collaborations 
together, and the Office continues to support 
and fund civil society engagement at the CND 
and other fora.
The International Narcotics  
Control Board
As stated above, the INCB is an independent, 
quasi-judicial expert body established by the 
1961 Single Convention on Narcotic Drugs. The 
Board was a merger of two predecessors: the 
Permanent Central Narcotics Board, created by 
the 1925 International Opium Convention; and the 
Drug Supervisory Body, created by the 1931 Con-
vention for Limiting the Manufacture and Regulat-
ing the Distribution of Narcotic Drugs. The INCB 
has 13 members, each elected by the Economic 
and Social Council for a period of five years. Ten 
of the members are elected from a list of per-
sons nominated by member states, and three 
are elected from a list of persons nominated 
by the WHO for their medical, pharmacologi-
cal or pharmaceutical experience. Members of 
the Board are expected to serve impartially in 
their personal capacity, independently of Gov-
ernments and can be re-elected (International 
Narcotics Control Board).
In order to fulfil its mandate, the INCB esti-
mates the quantities of narcotic drugs required 
for licit purposes and monitors licit production 
and trade of controlled substances through a 
system of export and import authorizations. It 
also works to improve the national and inter-
national control system by identifying weak-
nesses and providing recommendations to ad-
dress them. For this purpose, the Board also 
maintains an ongoing dialogue with Govern-
ments and assists them in complying with their 
obligations, such as preventing the diversion of 
substances from licit to illicit manufacture (In-
ternational Narcotics Control Board).
The INCB has been accelerating its engage-
ment with civil society in recent years – having 
at one point been widely regarded as a very se-
cretive and closed body as far as some NGOs 
were concerned (Barrett, 2008). At each CND 
meeting, the INCB President and Secretariat 
participate in an informal dialogue with civil 
society. With support from VNGOC, the INCB 
also now regularly seeks NGOs to meet with 
during their scheduled country visits every 
year. In May 2018, the INCB held its first ever 
Civil Society Hearing, with the VNGOC select-
ing ten civil society representatives from differ-
ent regions and perspectives to speak on “the use 
of cannabis for medical and non-medical purposes”, 
either in person and via video link. The second 
INCB Civil Society Hearing was then held in 
May 2019 on “young people and drugs” with eight 
civil society speakers selected, in what looks 
like becoming a mainstay of the INCB calen-
dar. Addiction professionals are often selected 
as speakers in these sessions and can apply to 
speak through the VNGOC. 
The INCB also issued a statement in late 
2019 on “The role of civil society in the development 
and implementation of drug policies on prevention, 
treatment and social reintegration”, supporting a 
health-centred approach to international drug 
policy, and reaffirming the important role of 
civil society in effective, evidence-based drug 
policies (International Narcotics Control Board, 
2019).
The World Health Organization
The WHO is an international body operating 
in 194 Member States across six regions, whose 
primary role is to direct and coordinate interna-
tional health within the United Nations system. 
Regarding the drug control system, WHO is re-
sponsible for assessing the medical properties 
of substances and making recommendations to 
the CND about their potential (re)scheduling 
through its Expert Committee on Drug Dependence 
(ECDD). The ECDD is an independent group 
of experts in the field of drugs and medicines, 
who assess the health risks and benefits of the 
use of psychoactive substances according to a 
set of fixed criteria. Depending on the outcome 
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of their assessments, the ECDD may advise that 
the CND place a substance under international 
control, transfer a substance from one Schedule 
to another, delete the substance from a Sched-
ule, or keep the substance under surveillance 
outside of the Schedules. The ECDD recommen-
dations are presented by the Director General 
of the WHO to the UN Secretary General and 
the CND who vote on whether to follow this ad-
vice (World Health Organization).
In Geneva, the WHO also engages with 
CSOs, as outlined in the 2016 Framework of en-
gagement with non-State actors through five main 
types of engagement: participation, resources, 
evidence, advocacy, and technical collaboration. 
The WHO is also actively working to improve 
civil society engagement through the recently 
established WHO-CSO Task Team, which is an-
other avenue that addiction professionals can 
explore (United Nations Foundation). WHO 
Expert Committee meetings such as the meet-
ings of the ECDD are not open to civil society, 
however “open sessions” are now held in which 
civil society representatives may register to 
participate in order to present information to 
committee members on relevant agenda items 
(World Health Organization). Returning to Vi-
enna, the most recent CND session held in 2020 
brought another opportunity for civil society to 
engage with the WHO with the addition of an-
other “informal dialogue” session held between 
civil society and the WHO Mental Health and 
Substance Use Department. 
Other UN agencies
The interplay of work conducted by the WHO 
and Office of the High Commissioner on Hu-
man Rights (OHCHR), i. e. creation of the UN 
Task Force on Transnational Organised Crime and 
Drug Trafficking and adoption of the 2030 Sus-
tainable Development Agenda for the UN System 
in 2015, have highlighted the strong need for 
UN interagency approaches to address drug-
related matters globally. Since the adoption of 
the Single Convention, international drug control 
measures have highlighted the concern of im-
plementing drug control measures that “respect 
the health and welfare of human beings” and 
“respect fundamental human rights” (United 
Nations, 2013).
In the lead up to the 2016 UNGASS session, 
multiple UN agencies made submissions upon 
invitation by the UN General Assembly in or-
der to achieve an inclusive preparatory process 
for the session. This process shows the intricacy 
of drug-related matters across UN entities, as 
the General Assembly received submissions 
from many UN agencies (United Nations Office 
of Drugs and Crime, 2016), detailing the impor-
tance of incorporating civil society in drug-re-
lated matters.
Finally, in the lead up to the most recent 
milestone UN meeting on drug-related matters, 
the 2019 High-Level Ministerial Segment at the 
CND, the UN System produced the “UN System 
Common Position supporting the implementation 
of the international drug control policy through ef-
fective interagency collaboration”. This document 
recognises that “the concern for the health and 
welfare of humankind underpins the three in-
ternational drug control conventions” and aims 
to “support the development and implemen-
tation of policies that put people, health and 
human rights at the centre”. The document is 
also a further endorsement of the work being 
done by civil society organisations in respect 
of prevention, harm reduction, treatment, reha-
bilitation, access to medicines, universal health 
coverage, alternatives to conviction and punish-
ment, measures to reduce stigma and eliminate 
discrimination, and “changes in laws, policies 
and practices that threaten the health and hu-
man rights of people” (UN system coordination 
Task Team on the Implementation of the UN 
System Common Position on drug-related mat-
ters, 2019).
Opportunities to influence  
international drug policy by civil  
society 
As a result of the continuous advocacy and en-
gagement of NGOs working on drug-related 
matters, and the growing acknowledgement 
and respect being achieved from member states 
and UN agencies, there are now many ways in 
which civil society groups, including addiction 
practitioners, can and should engage in drug-
related UN processes to influence policies and 
practices. While some are of the opinion that 
the most impactful civil society interventions 
take form outside of official processes, there is 
little doubt that the increased civil society pres-
ence and participation has contributed to a shift 
in the general narratives at the UN in Vienna. 
There is more focus than ever before on public 
health, human rights and balanced policy re-
sponses. Against a global backdrop where civil 
society space is increasingly shrinking and is 
threatened (CIVICUS Monitor, 2019), this is a 
welcome development.
Today, general options for engagement 
include: participating in CND sessions (by 
physically attending the meetings, submit-
ting written and oral statements, coordinating 
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or participating in side events, and engaging 
with – or even being invited on to – government 
delegations); engaging via the VNGOC and 
NYNGOC (by joining the Committees, submit-
ting applications for the open calls for speakers 
that are launched for various UN meetings, and 
participating in surveys and consultations held 
by UNODC and others).
CND sessions
The CND meeting may be one of the few occa-
sions that civil society representatives have the 
opportunity to meet with senior government 
officials and policymakers – and vice versa. 
This is an opportunity for civil society, includ-
ing addiction professionals, to build relation-
ships with diplomats working in Vienna, but 
also with those developing and implementing 
policy and practice in capitals. Meeting over 
coffee, lunch, at a side event or reception allows 
for informal discussion and the chance to relay 
the expertise, viewpoints, evidence and experi-
ences that civil society has. It can also provide 
a basis for future collaboration and partnership 
between civil society and Member States.
Most other international treaty regimes 
have built-in monitoring and evaluation mech-
anisms to review implementation problems 
encountered by the parties (Chesterman, 2019). 
Since the three drug control conventions lack 
such mechanisms that enable the evolution of 
the system over time, civil society are especial-
ly important contributors in the system design 
of international efforts to reduce drug related 
problems. 
Typically, any NGO with a valid ECOSOC 
status can send a physical civil society delega-
tion of up to ten people to the main CND meet-
ing, although this number may be changed due 
to online and hybrid UN sessions currently be-
ing held as a result of the COVID-19 pandemic 
around the world. NGOs without this status 
can ask others to include them in their delega-
tions instead. For those unable to attend the 
CND, NGOs can engage in a variety of ways – 
submitting written statements (up to 2,000 
words), following the proceedings online via 
webcasts, social media and blogs, or finding out 
who forms the national delegation and request-
ing to meet them before or after the CND meet-
ing (ideally as part of a network of NGOs). The 
VNGOC and NYNGOC are primed to support 
and advise any NGOs wishing to engage and 
navigate these options. The VNGOC produces 
a civil society guide to CND each year. This 
guide can be found at https://vngoc.org/.
Conclusion
International debates and decisions directly in-
fluence and shape on-the-ground practice in the 
field of addiction. Though national policies are 
generally made on the state-level, signatories of 
the drug control conventions are bound to fol-
low their commitments to the treaties and have 
limited sovereignty in unilaterally regulating 
internationally scheduled substances. The nar-
ratives, power-dynamics and decisions on the 
highest levels trickle down to regional policy 
making, so it is very important to shift the de-
bate from substances to people at the highest 
level, so drug policies can operate effectively on 
the national level.
With Member States coming together each 
year at the CND to agree on ways forward in in-
ternational drug policy, adopt resolutions and 
vote on key issues, a significant opportunity to 
engage with the process lies in Vienna. Any or-
ganization with an ECOSOC status can attend 
these meetings and, with the help of the Vien-
na and New York NGO Committees, can take 
part in the proceedings. The NGO Committees’ 
regular newsletters and respective communi-
cations channels offer up-to-date information 
about current opportunities for members of civ-
il society, and through their online marketplace 
(mp.vngoc.org) provide a platform for organiza-
tions to follow trends across the globe.
Civil society engagement and attendance at 
CND sessions throughout the year is crucial, 
in order to bring “real world” issues and the 
voices of affected populations to the forefront 
of the UN debates. Addiction practitioners are 
critical in relaying information on evidence-
based practice to these forums, to ensure that 
international drug policies follow scientific 
evidence and not preconceived ideologies, and 
to guarantee health-centred and rights-based 
approaches prevail in the global drug control 
framework. 
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Moderate Tabaksteuererhöhung:  
vertane Chance für die  
Gesundheitsprävention
Nach Informationen des Nachrichtenma-
gazins „Der Spiegel“ plant Bundesfinanz-
minister Olaf Scholz, ab dem 1. Januar 
2022 die Tabaksteuer in fünf Schritten 
moderat zu erhöhen.
Zu der vorgeschlagenen Tabaksteuer­
erhöhung sagt Katrin Schaller, kom­
missarische Leiterin der Stabstelle 
Krebsprävention am Deutschen Krebs­
forschungszentrum: „Wir begrüßen 
grundsätzlich den Vorstoß für eine Er­
höhung der Tabaksteuern. Wiederhol­
te, spürbare Tabaksteuererhöhungen 
sind die wirksamste Maßnahme, um 
Raucherinnen und Raucher zum Nicht­
rauchen zu motivieren und so zahlrei­
chen tabakrauchbedingten Krebser­
krankungen vorzubeugen – allerdings 
nur, wenn sie tatsächlich den Zigaret­
tenpreis deutlich erhöhen. Da beson­
ders Jugendliche, denen meist wenig 
Geld zur Verfügung steht, bis zu dreimal 
stärker auf Preiserhöhungen reagieren 
als Erwachsene, schützen deutliche Ta­
baksteuererhöhungen Jugendliche vor 
dem Einstieg ins Rauchen und dienen 
in besonderem Maße dem Jugend­
schutz.“
Die nun geplante Erhöhung um fünf 
Cent pro Packung und Jahr sind viel zu 
wenig, um Menschen zu motivieren, mit 
dem Rauchen aufzuhören. Um gesund­
heitspolitisch wirksam zu sein, müssen 
Studien zufolge die Preise jährlich um 
mindestens zehn Prozent erhöht wer­
den – im ersten Schritt also um etwa 60 
Cent.
Nach Ansicht der Präventionsexper­
tin spielen die vorgeschlagenen mode­
raten Erhöhungen der Tabakindustrie 
in die Hände: An solche geringen Preis­
erhöhungen gewöhnen sich Raucherin­
nen und Raucher leichter und rauchen 
weiter – genau dies erhoffen sich die 
Hersteller.
Das DKFZ fordert daher die Politik 
auf, der gesundheitspolitisch bedeut­
samen Lenkwirkung der Tabaksteuern 
die erforderliche große Bedeutung bei­
zumessen und die Steuern um jährlich 
zehn Prozent zu erhöhen. Nur so kann 
die Steuererhöhung als wichtiges Inst­
rument für die Gesundheitsprävention 
Wirkung zeigen. ■r
International drug policy: the impact of civil society and opportunities for addiction professionals to engage 121
rausch, 9. Jahrgang, 3/4-2020
www.incb.org/incb/en/about/mandate-func 
tions.html
International Narcotics Control Board. (2019). The 
role of civil society in the development and imple-
mentation of drug policies on prevention, treatment 
and social reintegration. Vienna: United Nations. 
Retrieved from: https://www.incb.org/docu 
ments/News/Alerts/Alert16_CES_Essay_civ 
il_society_Dec_2019.pdf
New York NGO Committee on Drugs. (n.d.). Re-
trieved from https://nyngoc.org/
NGO Committee on Narcotics and Substance 
Abuse. (1994). Bangkok declaration of the 1994 non-
government organizations (NGOs). World forum 
on drug demand reduction. Retrieved from: http: 
//w w w.u it t i .ne t/u n ngon s a/1994 NGO 
Bangkok.htm
The Commission on Narcotic Drugs. (2009). Reso-
lution 51/4: Preparations for the high-level seg-
ment of the fifty-second session of the commission 
on narcotic drugs, relating to the follow-up to the 
twentieth special session of the general assembly. 
Vienna: United Nations Office of Drugs and 




The Commission on Narcotic Drugs. (2011). Reso-
lution 54/11: Improving the participatory role of 
civil society in addressing the world drug problem. 
Vienna: United Nations Office of Drugs and 




UN system coordination Task Team on the Imple-
mentation of the UN System Common Posi-
tion on drug-related matters. (2019). What we 
have learned over the last ten years: A summary of 
knowledge acquired and produced by the UN sys-
tem on drug-related matters. New York: United 
Nations. Retrieved from: https://www.unodc.
org/documents/commissions/CND/2019/
Contr ibut ions/UN_Ent it ies/What_we_
have_learned_over_the_last_ten_years_-_14_
March_2019_-_w_signature.pdf
United Nations. (n.d.). Transforming our world: the 
2030 agenda for sustainable development. Re-
trieved from: https://sustainabledevelopment.
un.org/post2015/transformingourworld
United Nations. (2013). The international drug 





United Nations Department of Economic and So- 
cial Affairs. (n.d.). Working with ECOSOC: an 
NGOs guide to consultative status. Retrieved from: 
https://www.un.org/development/desa/ 
dspd/civil-society/ecosoc-status.html
United Nations Foundation. (n.d.). Together for the 
triple billion: a new era of partnership between the 
World Health Organization (WHO) and civil soci-
ety. Retrieved from https://civilsociety4health.
org/
United Nations General Assembly. (1990). Political 
declaration and programme of action 1990. New 





United Nations General Assembly. (1998a). Decla-
ration on the guiding principles of drug demand 
reduction: resolution/adopted by the general as-
sembly. New York. Retrieved from: https://digi 
tallibrary.un.org/record/261563
United Nations General Assembly. (1998b). 
Resolution adopted by the general assembly: po-
litical declaration. New York. Retrieved from 
https://www.unodc.org/documents/com 
m ission s/CND/Pol it ica l _Dec larat ion/
Political_Declaration_1998/1998-Political-
Declaration_A-RES-S-20-2.pdf
United Nations Office of Drugs and Crime. (n.d.). 
Commission on narcotic drugs: membership and 
bureau. Retrieved from: https://www.unodc.
org/unodc/en/commissions/CND/Member-
ship/Membership.html
United Nations Office of Drugs and Crime. (n.d.). 




United Nations Office of Drugs and Crime. (n.d.). 
Our main civil society partners. Retrieved from: 
https://www.unodc.org/unodc/en/ngos/Civ-
il-Society-partners.html
United Nations Office of Drugs and Crime. (n.d.). 




United Nations Office of Drugs and Crime. (1987). 
42/112. International conference on drug abuse and 
illicit trafficking. Retrieved from: https://www.
unodc.org/unodc/en/Resolutions/resolu 
tion_1987-12-07_2.html
United Nations Office of Drugs and Crime. (1991). 
1991/47. United Nations international drug con-
trol programme. Retrieved from: https://www.
unodc.org/unodc/en/Resolutions/resolu 
tion_1991-06-21_9.html
United Nations Office of Drugs and Crime. (2008). 
“BEYOND 2008” – Contribution of non-govern-
mental organizations to the implementation of the 
political declaration and action plans adopted by 
P. hill, O. Fehér & J. Bridge122
rausch, 9. Jahrgang, 3/4-2020
the twentieth special session of the general assem-




United Nations Office of Drugs and Crime. (2009). 
Political declaration and plan of action on inter-
national cooperation towards an integrated and 
balanced strategy to counter the world drug prob-




United Nations Office of Drugs and Crime. (2016). 
UN entities – Contributions to the 2016 UNGASS. 
Retrieved from: https://www.unodc.org/un 
gass2016/en/contribution_UN_Entities.html
United Nations Office of Drugs and Crime. (2019a). 
Ministerial declaration on strengthening our actions 
at the national, regional and international levels to 
accelerate the implementation of our joint commit-
ments to address and counter the world drug prob-




United Nations Office of Drugs and Crime. (2019b). 
UNODC hosts civil society hearing to strengthen 






United Nations Office of Drugs and Crime. (2020) 
Scheduling procedures under the international 
drug control conventions. Vienna: United Na-




Vienna NGO Committee on Drugs. (n.d.). Member-
ship. Retrieved from https://vngoc.org/about-
the-vngoc/membership/
Vienna NGO Committee on Drugs. (n.d.). Vien-
na NGO committee on drugs. Retrieved from: 
https://vngoc.org/about-the-vngoc/welcome-
to-the-vngoc-e-home/
World Health Organization. (n.d.). Open session 
of the 42nd ECDD. Retrieved from: https://
www.who.int/medicines/access/controlled-
substances/42nd_ecdd_open-session/en/
World Health Organization. (n.d.). WHO expert 
committee on drug dependence. Retrieved from 
https://www.who.int/medicines/access/con 
trolled-substances/ecdd/en/
Orsolya Fehér, BSc (Economics),  
MSc (Communication Science) 
She is a Global Fellow for Students for Sensible 
Drug Policy – an international grassroots organiza-
tion that mobilizes and empowers young people 
to participate in political processes – and, as such, 
has served on the board of the VnGOc 2018–2020. 
Orsi is also the co-founder and Managing Director 
of Psycare Austria, a psychedelic harm reduction. 
organisation.
Jamie Bridge,  
BSc (Psychology), MSc (Drug Policy)
he is the chief Operating Officer for the Internati-
onal Drug Policy consortium (IDPc) – a global net-
work of non-governmental organisations calling for 
more humane and rights-based drug policies. Jamie 
is also the chair of the Vienna nGO committee on 
Drugs (VnGOc).
Penelope L. Hill, BHS, MSc (Public Health), 
GradDip DevStud (International Develop-
ment)
She is a current PhD candidate and research assis-
tant at the Burnet Institute in Melbourne, Austra-
lia, investigating the impact of health service use 
on opioid overdose incidence among people who 
inject drugs. She also works as a harm reduction 
worker across various outreach programs for people 
who use drugs. She is the Vienna nGO committee 
deputy secretary and Oceania representative on the 
Members Advisory committee of the International 
Drug Policy consortium.
info@vngoc.org
